Actively Recruiting
Effects of a Collagen Supplement on Quality of Life, Appetite and Glycaemic Control
Led by King's College London · Updated on 2025-11-14
100
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
Sponsors
K
King's College London
Lead Sponsor
R
Rousselot BVBA
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a clinical trial aimed to investigate if a collagen supplement can improve quality of life, appetite and blood sugar in overweight and obese adults aged 18-65. Hypothesis: Consumption of a collagen supplement for 8 days will improve quality of life and improve glycaemic control in comparison with a placebo in individuals overweight or with obesity with a perceived low quality of life. Participants will be asked to: 1. Consume a collagen peptide supplement for a total of 8 days at a time 2. Fill in questionnaires about quality of life, appetite, mood and energy 3. Wear continuous glucose monitors
CONDITIONS
Official Title
Effects of a Collagen Supplement on Quality of Life, Appetite and Glycaemic Control
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy adults aged 18 to 65 years who are overweight or obese with a BMI of 25 to 40 kg/m2
- Participants with impaired quality of life based on specific questionnaire scores for energy, mood, and sleep
- Must have email, internet access, and a compatible smartphone for virtual visits and online questionnaires
- Willing and able to comply with all study procedures including supplement intake, continuous glucose monitoring for 22 days, meal tests, and questionnaires
- Willing to take a supplement containing bovine animal products
- Open to participating in an online interview at the end of the study
You will not qualify if you...
- History or presence of uncontrolled or significant pulmonary, cardiac, liver, kidney, endocrine (including diabetes), blood, immune, neurological, psychiatric, or biliary diseases
- Significant gastrointestinal conditions affecting study evaluation, including inflammatory bowel disease, irritable bowel syndrome, severe constipation, frequent diarrhea, weight loss surgery, gastroparesis, or lactose intolerance
- Chronic insomnia or diagnosed sleep disorders or medical conditions impacting energy or fatigue
- Pregnant, planning pregnancy, lactating, or unwilling to use approved contraception if of childbearing potential
- Known allergy, intolerance, or sensitivity to study product ingredients including bovine products
- History of cancer in the past two years except non-melanoma skin cancer
- Recent major trauma or surgery within three months prior to study start
- Unstable use of medications or supplements that may affect trial outcomes
- Participation in another biomedical study within 30 days before screening
- Employment or financial interest in the study sponsor company
- Conditions interfering with informed consent or study compliance
- Vegan, vegetarian, or cultural/religious exclusion of bovine products
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Metabolic Research Unit (KCL, Waterloo Campus)
London, London, United Kingdom, SE1 9NH
Actively Recruiting
Research Team
A
Alex Cheok, PhD
CONTACT
A
Ana Rodriguez-Mateos, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here